Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

HealthLynked (HLYK) EBITDA Margin (2016 - 2025)

HealthLynked (HLYK) has disclosed EBITDA Margin for 10 consecutive years, with 228.59% as the latest value for Q4 2025.

  • Quarterly EBITDA Margin fell 65994.0% to 228.59% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 144.5% through Dec 2025, down 10553.0% year-over-year, with the annual reading at 28.42% for FY2025, 1055.0% up from the prior year.
  • EBITDA Margin for Q4 2025 was 228.59% at HealthLynked, down from 184.41% in the prior quarter.
  • The five-year high for EBITDA Margin was 431.34% in Q4 2024, with the low at 293.09% in Q4 2022.
  • Average EBITDA Margin over 5 years is 88.1%, with a median of 106.9% recorded in 2022.
  • The sharpest move saw EBITDA Margin skyrocketed 54742bps in 2024, then tumbled -65994bps in 2025.
  • Over 5 years, EBITDA Margin stood at 94.71% in 2021, then crashed by -409bps to 293.09% in 2022, then skyrocketed by 60bps to 116.08% in 2023, then skyrocketed by 472bps to 431.34% in 2024, then crashed by -153bps to 228.59% in 2025.
  • According to Business Quant data, EBITDA Margin over the past three periods came in at 228.59%, 184.41%, and 110.67% for Q4 2025, Q3 2025, and Q2 2025 respectively.